Tango Therapeutics(TNGX) - 2023 Q4 - Annual Report

Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Securities registered pursuant to Section 12(g) of the Act: None Commission File Number 001-39485 TANGO THERAPEUTICS, INC. (Exact name of Registrant as specifie ...